Concepedia

Publication | Open Access

The Fully human anti-CD47 antibody SRF231 exerts dual-mechanism antitumor activity via engagement of the activating receptor CD32a

DOIFull Paper Access

53

Citations

43

References

2020

Year

Marisa O. Peluso, Ammar Adam, Caroline M Armet, Li Zhang, Rachel W O’Connor, Benjamin H. Lee, Andrew C. Lake, Emmanuel Normant, Scott C. Chappel, Jonathan A. Hill,
Journal for ImmunoTherapy of Cancer

Abstract

SRF231 elicits antitumor activity via apoptosis and phagocytosis involving macrophage engagement in a manner dependent on the FcγR, CD32a.

References

YearCitations

Page 1